SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,520.87 233.75
(0.47%)

Dow Jones

6,986.78 44.32
(0.64%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,123.15 78.46
(0.78%)

Forex

USD-INR

89.91 -0.02
(-0.02%)

EUR-INR

104.90 -0.20
(-0.19%)

GBP-INR

120.86 -0.43
(-0.35%)

JPY-INR

0.57 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Infollion Research Services Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

78698

INE0NNZ01013

55.6873548

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFOLLION

33.78

369.79

EPS(TTM)

Face Value()

Div & Yield %

11.29

Back

Concord Drugs consolidated net profit rises 300.00% in the June 2025 quarter

Aug 09,2025

Net profit of Concord Drugs rose 300.00% to Rs 0.12 crore in the quarter ended June 2025 as against Rs 0.03 crore during the previous quarter ended June 2024. Sales rose 16.42% to Rs 13.61 crore in the quarter ended June 2025 as against Rs 11.69 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	13.61	11.69	16
OPM %	7.49	7.10	-
PBDT	0.53	0.38	39
PBT	0.16	0.04	300
NP	0.12	0.03	300

83,576.24 -604.72 ( -0.72%)

49,520.87 233.75 (0.47%)

6,986.78 44.32 (0.64%)

51,918.01 800.75 (1.57%)

10,123.15 78.46 (0.78%)

89.91 -0.02 (-0.02%)

104.90 -0.20 (-0.19%)

120.86 -0.43 (-0.35%)

0.57 0.00 (-0.15%)